EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials

Godwin Yung iD, Kaspar Rufibach iD, Marcel Wolbers, Ray Lin, Yi Liu

Statistics in Medicine · 2025

DOI: 10.1002/sim.70101 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Godwin Yung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Statistical Methods Collaboration and Outreach Group, F. Hoffmann-La Roche AG, California, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We revisit the question of what randomization ratio (RR) maximizes the power of the logrank test (LRT) in event‐driven survival trials under proportional hazards (PH). By comparing three approximations of the LRT (Schoenfeld, Freedman, and Rubinstein) to empirical simulations, we find that the RR that maximizes power is the RR that balances the number of events across treatment arms at the end of the trial. This contradicts the common misconception implied by Schoenfeld's approximation that 1:1 randomization maximizes power. Besides power, we consider other factors that might influence the choice of RR (accrual, trial duration, sample size, etc.). We perform simulations to better understand how unequal randomization might impact these factors in practice. Altogether, we derive 5 insights to guide statisticians in the design of survival trials considering unequal randomization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicHumansSurvival AnalysisComputer SimulationProportional Hazards ModelsModels, StatisticalSample SizeRandom Allocation

Stichwörter der Autor:innen

proportional hazardsrandomization ratiosurvival studytime‐to‐event

Autor:innen und Institutionen

  • Statistical Methods Collaboration and Outreach Group, F. Hoffmann-La Roche AG, California, USA.
  • Statistical Methods Collaboration and Outreach Group, F. Hoffmann-La Roche AG, Basel, Switzerland.
  • Department of Biostatistics, Nektar Therapeutics, California, USA.

ORCID-Profile: Godwin Yung, Kaspar Rufibach

Zitieren

APA

Yung, G., Rufibach, K., Wolbers, M., Lin, R., & Liu, Y. (2025). Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials. Statistics in Medicine. https://doi.org/10.1002/sim.70101

Vancouver

Yung G, Rufibach K, Wolbers M, Lin R, Liu Y. Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials. Statistics in Medicine. 2025. doi:10.1002/sim.70101

BibTeX
@article{Yung2025,
  author = {Yung, Godwin and Rufibach, Kaspar and Wolbers, Marcel and Lin, Ray and Liu, Yi},
  title = {Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70101}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche